Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the DIVAS-Q (Day to Day Impact of Vulvovaginal Atrophic Symptoms Questionnaire) A Portuguese Patient-Reported Outcome Measure

NCT07250490 is registered in ClinicalTrials.gov with Instituto Politécnico de Leiria as lead sponsor.

NCT NCT07250490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07250490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the DIVAS-Q (Day to Day Impact of Vulvovaginal Atrophic Symptoms Questionnaire) A Portuguese Patient-Reported Outcome Measure
Lead sponsor
Instituto Politécnico de Leiria
Phase
Observational
Overall status
Completed
Start date
October 2, 2022
Completion date
September 4, 2025
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital disorder, proms, vulvovaginal atrophy